drugset / Trial / NCT02040883
Tandospirone Combined With Atypical Antipsychotic Drugs in Schizophrenia
RandomizedParallel-groupSingle-blindTreatment
Summary
Efficacy and safety of Tandospirone combined with Atypical Antipsychotic drugs to Improve Cognitive function in Schizophrenia
Timeline
- Start
- 2014-02
- Primary completion
- 2014-12
- Completion
- 2014-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tandospirone | Small molecule | 30 mg | — |
| Background | Aripiprazole | Other / unclassified | — | — |
| Background | Olanzapine | Small molecule | — | — |
| Background | Quetiapine | Small molecule | — | — |
| Background | Risperidone | Other / unclassified | — | — |
| Background | Ziprasidone | Small molecule | — | — |